Clinical Report: Impact of the COVID-19 Pandemic on Cancer Screening Disparities
Background
Cancer screening is crucial for early detection and improved outcomes, yet disparities persist among various demographic groups. The COVID-19 pandemic disrupted healthcare services, leading to delays in cancer screenings, which may exacerbate existing inequalities.
Data Highlights
The study utilized longitudinal data from the NSHAP surveys conducted in 2015-2016 and 2021-2023, focusing on colorectal, prostate, and breast cancer screening rates among middle-aged and older adults.
Key Findings
Overall cancer screening rates recovered by 2023, but disparities persisted among certain subpopulations.
Hispanic patients and Black women showed lower screening rates compared to their non-Hispanic white counterparts.
Unmarried individuals exhibited lower rates of cancer screenings across multiple types.
Changes in USPSTF guidelines during the pandemic influenced screening behaviors.
One-third of older adults reported delaying medical care due to the pandemic.
Clinical Implications
Healthcare providers should be aware of the ongoing disparities in cancer screening rates exacerbated by the pandemic. Targeted interventions may be necessary to improve access and encourage screening among underrepresented groups.
Conclusion
The findings underscore the need for continued monitoring of cancer screening rates and targeted efforts to address disparities in the wake of the COVID-19 pandemic.
